Assenagon Asset Management S.A. Vertex Pharmaceuticals Inc Transaction History

Assenagon Asset Management S.A.

$54.8 Billion
Q1 2025

A detailed history of Assenagon Asset Management S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 208,140 shares of VRTX stock, worth $92.9 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

208,140

Previous 839,672 75.21%

Holding current value

$92.9 Million

Previous $338 Million 70.16%

% of portfolio

0.18%

Previous 0.63%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$402.49 - $513.76 $254 Million - $324 Million	-631,532 Reduced 75.21%	208,140 $101 Million
Q4 2024 Jan 14, 2025	BUY	$396.64 - $516.74 $209 Million - $273 Million	528,029 Added 169.43%	839,672 $338 Million
Q3 2024 Oct 23, 2024	BUY	$460.0 - $505.78 $99.1 Million - $109 Million	215,448 Added 223.97%	311,643 $145 Million
Q2 2024 Jul 18, 2024	SELL	$392.81 - $485.53 $89.1 Million - $110 Million	-226,893 Reduced 70.23%	96,195 $45.1 Million
Q1 2024 Apr 24, 2024	BUY	$407.69 - $446.08 $11 Million - $12 Million	26,935 Added 9.09%	323,088 $135 Million
Q4 2023 Jan 17, 2024	BUY	$343.0 - $410.68 $32.2 Million - $38.6 Million	93,922 Added 46.44%	296,153 $121 Million
Q3 2023 Nov 06, 2023	SELL	$338.18 - $362.46 $61.7 Million - $66.1 Million	-182,487 Reduced 47.43%	202,231 $70.3 Million
Q2 2023 Jul 25, 2023	SELL	$314.42 - $351.91 $73.6 Million - $82.4 Million	-234,078 Reduced 37.83%	384,718 $135 Million
Q1 2023 Apr 18, 2023	SELL	$283.23 - $323.1 $34 Million - $38.8 Million	-120,191 Reduced 16.26%	618,796 $195 Million
Q4 2022 Jan 12, 2023	BUY	$285.76 - $321.48 $21.9 Million - $24.7 Million	76,752 Added 11.59%	738,987 $213 Million
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $40 Million - $44.7 Million	146,237 Added 28.34%	662,235 $192 Million
Q2 2022 Jul 27, 2022	SELL	$234.96 - $292.55 $68.7 Million - $85.6 Million	-292,556 Reduced 36.18%	515,998 $145 Million
Q1 2022 Apr 25, 2022	BUY	$221.42 - $260.97 $108 Million - $127 Million	486,323 Added 150.92%	808,554 $211 Million
Q4 2021 Feb 01, 2022	BUY	$177.01 - $223.45 $44.7 Million - $56.5 Million	252,752 Added 363.78%	322,231 $70.8 Million
Q3 2021 Oct 19, 2021	SELL	$181.39 - $202.99 $30.2 Million - $33.8 Million	-166,649 Reduced 70.58%	69,479 $12.6 Million
Q2 2021 Jul 15, 2021	SELL	$187.49 - $221.1 $7.06 Million - $8.32 Million	-37,631 Reduced 13.75%	236,128 $47.6 Million
Q1 2021 Apr 26, 2021	SELL	$207.02 - $241.31 $67.2 Million - $78.4 Million	-324,687 Reduced 54.26%	273,759 $58.8 Million
Q4 2020 Feb 01, 2021	BUY	$207.01 - $276.09 $98.1 Million - $131 Million	474,130 Added 381.39%	598,446 $141 Million
Q3 2020 Oct 07, 2020	SELL	$255.65 - $303.1 $335,924 - $398,273	-1,314 Reduced 1.05%	124,316 $33.8 Million
Q2 2020 Jul 21, 2020	SELL	$225.48 - $295.8 $145 Million - $190 Million	-641,941 Reduced 83.63%	125,630 $36.5 Million
Q1 2020 Apr 17, 2020	BUY	$199.77 - $247.81 $99.5 Million - $123 Million	498,163 Added 184.91%	767,571 $183 Million
Q4 2019 Jan 17, 2020	BUY	$166.71 - $223.91 $40.1 Million - $53.9 Million	240,816 Added 842.25%	269,408 $59 Million
Q3 2019 Oct 16, 2019	BUY	$166.23 - $187.09 $3.21 Million - $3.62 Million	19,333 Added 208.8%	28,592 $4.84 Million
Q2 2019 Aug 12, 2019	SELL	$164.61 - $190.37 $9.76 Million - $11.3 Million	-59,305 Reduced 86.5%	9,259 $1.7 Million
Q1 2019 Apr 26, 2019	SELL	$163.73 - $194.7 $51.6 Million - $61.4 Million	-315,198 Reduced 82.13%	68,564 $12.6 Million
Q4 2018 Jan 23, 2019	BUY	$151.91 - $192.21 $29.2 Million - $37 Million	192,494 Added 100.64%	383,762 $63.6 Million
Q3 2018 Oct 29, 2018	SELL	$167.73 - $192.74 $29.1 Million - $33.4 Million	-173,500 Reduced 47.56%	191,268 $36.9 Million
Q2 2018 Jul 17, 2018	BUY	$145.72 - $169.96 $31 Million - $36.1 Million	212,481 Added 139.53%	364,768 $62 Million
Q1 2018 Apr 30, 2018	SELL	$151.6 - $177.13 $953,109 - $1.11 Million	-6,287 Reduced 3.96%	152,287 $24.8 Million
Q4 2017 Jan 25, 2018	SELL	$137.28 - $155.55 $101 Million - $114 Million	-734,806 Reduced 82.25%	158,574 $23.8 Million
Q3 2017 Oct 18, 2017	BUY	$148.13 - $162.24 $132 Million - $145 Million	893,380	893,380 $136 Million

Others Institutions Holding VRTX

# of Institutions

1,832

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $115B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Vertex Pharmaceuticals Inc Transaction History